St. Johns Investment Management Company LLC Has $1.33 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

St. Johns Investment Management Company LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.6% during the fourth quarter, Holdings Channel reports. The fund owned 2,524 shares of the healthcare conglomerate’s stock after selling 207 shares during the quarter. St. Johns Investment Management Company LLC’s holdings in UnitedHealth Group were worth $1,329,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the stock. Bray Capital Advisors raised its holdings in UnitedHealth Group by 0.5% during the third quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after buying an additional 50 shares during the last quarter. Middleton & Co. Inc. MA raised its holdings in UnitedHealth Group by 1.3% during the third quarter. Middleton & Co. Inc. MA now owns 29,513 shares of the healthcare conglomerate’s stock worth $14,880,000 after buying an additional 378 shares during the last quarter. First Merchants Corp raised its holdings in UnitedHealth Group by 2.9% during the third quarter. First Merchants Corp now owns 32,325 shares of the healthcare conglomerate’s stock worth $16,298,000 after buying an additional 916 shares during the last quarter. IFM Investors Pty Ltd grew its stake in shares of UnitedHealth Group by 3.2% in the 3rd quarter. IFM Investors Pty Ltd now owns 190,835 shares of the healthcare conglomerate’s stock worth $96,217,000 after acquiring an additional 5,837 shares in the last quarter. Finally, Source Financial Advisors LLC grew its stake in shares of UnitedHealth Group by 3.3% in the 3rd quarter. Source Financial Advisors LLC now owns 1,486 shares of the healthcare conglomerate’s stock worth $749,000 after acquiring an additional 47 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH traded up $5.78 on Friday, reaching $512.81. The company had a trading volume of 2,784,585 shares, compared to its average volume of 4,608,288. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The business has a 50 day simple moving average of $482.28 and a 200 day simple moving average of $511.82. The company has a market cap of $471.83 billion, a price-to-earnings ratio of 31.35, a P/E/G ratio of 1.47 and a beta of 0.55.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. During the same period last year, the business earned $6.26 earnings per share. The business’s quarterly revenue was up 8.6% on a year-over-year basis. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.47%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is 45.97%.

Wall Street Analyst Weigh In

UNH has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Stephens restated an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 8th. Truist Financial restated a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $570.05.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.